resveratrol has been researched along with salvianolic acid B in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Agboyibor, C; Bi, Y; Dong, J; Gong, H; Kang, L; Li, D; Li, J; Liu, H; Ma, X; Pervaiz, W; Tayyab, B; Zhang, H | 1 |
Gao, D; Gao, L; Hu, Y; Li, Z; Ma, X; Peng, J; Shan, W; Tian, X; Wang, G; Xu, W; Yao, J; Zeng, W; Zhang, N | 1 |
1 review(s) available for resveratrol and salvianolic acid B
Article | Year |
---|---|
A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors.
Topics: Carcinogenesis; Histone Demethylases; Humans; Neoplasms | 2022 |
1 other study(ies) available for resveratrol and salvianolic acid B
Article | Year |
---|---|
Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Topics: Animals; Benzofurans; Cytokines; Diet, High-Fat; Hep G2 Cells; HMGB1 Protein; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Protective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; RNA Interference; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Stilbenes; Up-Regulation | 2015 |